ESTHER
CULEBRAS LÓPEZ
Profesora asociada de Ciencias de la Salud
ICIAR
RODRÍGUEZ-AVIAL INFANTE
Profesora asociada de Ciencias de la Salud
Publications dans lesquelles il/elle collabore avec ICIAR RODRÍGUEZ-AVIAL INFANTE (51)
2023
-
Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents
PLoS ONE, Vol. 18, Núm. 3 March
-
High rates of colonization by Staphylococcus aureus in medical students before doing their clinical practices
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 251-253
2022
-
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 40, Núm. 4, pp. 172-178
-
Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
International Journal of Infectious Diseases, Vol. 114, pp. 85-87
-
Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
Medical Microbiology and Immunology, Vol. 211, Núm. 5-6, pp. 269-272
2021
-
Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America (Scientific Reports, (2021), 11, 1, (11442), 10.1038/s41598-021-90023-x)
Scientific Reports
-
Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America
Scientific Reports, Vol. 11, Núm. 1
-
Service-Learning, Movies, and Infectious Diseases: Implementation of an Active Educational Program in Microbiology as a Tool for Engagement in Social Justice
Frontiers in Microbiology, Vol. 12
-
Utilidad de MALDI-TOF y REP-PCR frente a PFGE para el estudio epidemiológico de Acinetobacter baumannii
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 3, pp. 207-213
2020
-
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Enfermedades Infecciosas y Microbiologia Clinica
-
Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19)
Ocular Immunology and Inflammation, Vol. 28, Núm. 6, pp. 922-925
-
Synergy of linezolid with several antimicrobial agents against linezolid-methicillin-resistant staphylococcal strains
Antibiotics, Vol. 9, Núm. 8, pp. 1-13
2019
-
Comparative evaluation of plazomicin MICs obtained using agar dilution versus broth microdilution methods and impact of inoculum size against ESBL-producing Escherichia coli, carbapenemase-producing Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus clinical isolates
Diagnostic Microbiology and Infectious Disease, Vol. 95, Núm. 3
-
Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain
Frontiers in Microbiology, Vol. 10, Núm. APR
2017
-
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing enterobacteriaceae
Journal of Medical Microbiology, Vol. 66, Núm. 2, pp. 169-174
-
In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
International Journal of Antimicrobial Agents, Vol. 50, Núm. 2, pp. 191-196
-
Plazomicin activity against 346 extended-spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates in relation to aminoglycoside-modifying enzymes
Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2
2016
-
Compendio de microbiología
Elsevier
2015
-
Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 10, pp. 5959-5966
-
In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
International Journal of Antimicrobial Agents